on 30 Nov 2016
Last Applicant/ Owned by
IMMUNOME INC.
3001 Market Street, Suite 140
PHILADELPHIA,, , 19104
Serial Number
UK00916112443 filed on 30th Nov 2016
Registration Number
UK00916112443 registered on
7th Apr 2017
Correspondent Information
Reddie & Grose LLP
The White Chapel Building, 10 Whitechapel High Street
London,
E1 8QS
Monoclonal antibodies for medical and scientific research; antibodies and immunoconjugates for medical and scientific research; proteins and components of proteins for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research.
Monoclonal antibodies and immunoconjugates for medical or clinical use; pharmaceutical compositions comprising monoclonal antibodies for use in the diagnosis, prevention, management and treatment of oncological, neurological, infectious disease, metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, opthalmic, respiratory, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; pharmaceutical compositions comprising immunoconjugates in the diagnosis, prevention, management and treatment of oncological, neurological, infectious disease, metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, opthalmic, respiratory, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; cells, cell extracts and components of cells for medical or clinical use; pharmaceutical preparations for use in the diagnosis, prevention, management and treatment of oncological, neurological, infectious disease, metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, opthalmic, respiratory, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; diagnostic preparations for medical use; diagnostic kits comprising reagents for medical and clinical use.
Biotechnology services, namely, development of monoclonal antibodies; pharmaceutical, medical, scientific, biopharmaceutical and biotechnology research and development; drug discovery services; providing medical and scientific research information in the field of medicine and pharmaceuticals.
UK00916112443
Word
Individual